CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
157.04
1.39%
Market Trading Hours* (UTC) Opens on Thursday at 08:10

Mon - Thu: 08:10 - 00:00

Fri: 08:10 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.95
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Johnson & Johnson ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 159.25
Open* 158.95
1-Year Change* -4.04%
Day's Range* 155.25 - 159.15
52 wk Range 150.11-181.04
Average Volume (10 days) 18.22M
Average Volume (3 months) 476.79M
Market Cap 385.35B
P/E Ratio 32.43
Shares Outstanding 2.41B
Revenue 97.77B
EPS 4.93
Dividend (Yield %) 2.97444
Beta 0.55
Next Earnings Date Oct 17, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 26, 2023 159.00 -0.59 -0.37% 159.59 160.06 158.43
Sep 25, 2023 160.34 -0.11 -0.07% 160.45 160.86 158.65
Sep 22, 2023 160.67 -0.78 -0.48% 161.45 161.62 159.95
Sep 21, 2023 161.53 -0.90 -0.55% 162.43 163.42 161.51
Sep 20, 2023 162.39 0.35 0.22% 162.04 163.48 161.14
Sep 19, 2023 162.15 -0.07 -0.04% 162.22 162.78 161.31
Sep 18, 2023 162.67 1.42 0.88% 161.25 163.09 160.69
Sep 15, 2023 161.43 -2.36 -1.44% 163.79 164.75 160.95
Sep 14, 2023 163.47 -0.11 -0.07% 163.58 165.19 163.05
Sep 13, 2023 163.97 0.44 0.27% 163.53 164.89 162.95
Sep 12, 2023 163.45 0.84 0.52% 162.61 163.87 161.45
Sep 11, 2023 162.15 1.56 0.97% 160.59 162.65 160.39
Sep 8, 2023 160.42 0.54 0.34% 159.88 160.71 158.79
Sep 7, 2023 159.65 1.79 1.13% 157.86 160.92 157.86
Sep 6, 2023 157.85 -3.00 -1.87% 160.85 160.85 157.19
Sep 5, 2023 160.60 0.30 0.19% 160.30 161.82 160.13
Sep 1, 2023 159.95 -1.79 -1.11% 161.74 162.32 159.85
Aug 31, 2023 161.36 -2.33 -1.42% 163.69 164.07 161.12
Aug 30, 2023 163.36 -0.99 -0.60% 164.35 165.64 161.48
Aug 29, 2023 163.97 0.01 0.01% 163.96 165.51 162.61

Johnson & Johnson Events

Time (UTC) Country Event
Tuesday, October 17, 2023

Time (UTC)

10:59

Country

US

Event

Q3 2023 Johnson & Johnson Earnings Call
Q3 2023 Johnson & Johnson Earnings Call

Forecast

-

Previous

-

Time (UTC)

12:30

Country

US

Event

Q3 2023 Johnson & Johnson Earnings Release
Q3 2023 Johnson & Johnson Earnings Release

Forecast

-

Previous

-
Tuesday, January 23, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 Johnson & Johnson Earnings Call
Q4 2023 Johnson & Johnson Earnings Call

Forecast

-

Previous

-

Time (UTC)

13:30

Country

US

Event

Q4 2023 Johnson & Johnson Earnings Release
Q4 2023 Johnson & Johnson Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 94943 93775 82584 82059 81581
Revenue 94943 93775 82584 82059 81581
Cost of Revenue, Total 30989 29855 28327 27456 26986
Gross Profit 63954 63920 54257 54603 54595
Total Operating Expense 73218 70999 66087 64731 63582
Selling/General/Admin. Expenses, Total 24765 24659 22084 22178 22540
Research & Development 14603 14714 12159 11355 10775
Interest Expense (Income) - Net Operating 814 -370 -410 -183 394
Unusual Expense (Income) 5004 4041 4428 1456 1826
Other Operating Expenses, Total -2957 -1900 -501 2469 1061
Operating Income 21725 22776 16497 17328 17999
Net Income Before Taxes 21725 22776 16497 17328 17999
Net Income After Taxes 17941 20878 14414 15119 15297
Net Income Before Extra. Items 17941 20878 14414 15119 15297
Net Income 17941 20878 14714 15119 15297
Income Available to Common Excl. Extra. Items 17941 20878 14414 15119 15297
Income Available to Common Incl. Extra. Items 17941 20878 14714 15119 15297
Diluted Net Income 17941 20878 14714 15119 15297
Diluted Weighted Average Shares 2663.9 2674 2670.7 2684.3 2728.7
Diluted EPS Excluding Extraordinary Items 6.73486 7.80778 5.39709 5.63238 5.60597
Dividends per Share - Common Stock Primary Issue 4.45 4.19 3.98 3.75 3.54
Diluted Normalized EPS 8.67833 9.22111 6.98515 7.87 6.92185
Total Extraordinary Items 300
Jul 2023 Apr 2023 Apr 2023 Jan 2023 Oct 2022
Total revenue 25530 24746 24746 23706 23791
Revenue 25530 24746 24746 23706 23791
Cost of Revenue, Total 8212 8395 8395 7711 7794
Gross Profit 17318 16351 16351 15995 15997
Total Operating Expense 18768 25483 25483 19505 17969
Selling/General/Admin. Expenses, Total 6665 6138 6138 6512 6089
Research & Development 3829 3563 3563 3841 3597
Interest Expense (Income) - Net Operating -23 80 -20 -77 101
Unusual Expense (Income) 445 7579 179 1871.2 723
Other Operating Expenses, Total -360 -272 7228 -353.2 -335
Operating Income 6762 -737 -737 4201 5822
Net Income Before Taxes 6762 -737 -737 4201 5822
Net Income After Taxes 5144 -68 -68 3520 4458
Net Income Before Extra. Items 5144 -68 -68 3520 4458
Net Income 5144 -68 -68 3520 4458
Income Available to Common Excl. Extra. Items 5144 -68 -68 3520 4458
Income Available to Common Incl. Extra. Items 5144 -68 -68 3520 4458
Diluted Net Income 5144 -68 -68 3520 4458
Diluted Weighted Average Shares 2625.7 2605.5 2605.5 2653.1 2661.3
Diluted EPS Excluding Extraordinary Items 1.9591 -0.0261 -0.0261 1.32675 1.67512
Dividends per Share - Common Stock Primary Issue 1.19 1.13 1.13 1.13 1.13
Diluted Normalized EPS 2.08802 1.87123 3.81117 2.02302 1.94069
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 55294 60979 51237 45274 46033
Cash and Short Term Investments 23519 31608 25185 19287 19687
Cash 4926 2936 2863 2637 2619
Cash & Equivalents 5368 1901 2102 2864 3397
Short Term Investments 13225 26771 20220 13786 13671
Total Receivables, Net 16160 15283 13576 14481 14098
Accounts Receivable - Trade, Net 16160 15283 13576 14481 14098
Total Inventory 12483 10387 9344 9020 8599
Prepaid Expenses 3132 3701 3132 2392 2699
Total Assets 187378 182018 174894 157728 152954
Property/Plant/Equipment, Total - Net 20903 19862 19766 18615 17035
Property/Plant/Equipment, Total - Gross 50353 48579 47804 44289 41851
Accumulated Depreciation, Total -29450 -28717 -28038 -25674 -24816
Goodwill, Net 45231 35246 36393 33639 30453
Intangibles, Net 48325 46392 53402 47643 47611
Other Long Term Assets, Total 17049 17655 12615 11409 11311
Total Current Liabilities 55802 45226 42493 35964 31230
Accounts Payable 11703 11055 9505 8544 7537
Accrued Expenses 29201 29293 28965 23952 20079
Notes Payable/Short Term Debt 11220 1635 832 0 0
Current Port. of LT Debt/Capital Leases 1551 2131 1799 1202 2297
Other Current Liabilities, Total 2127 1112 1392 2266 1317
Total Liabilities 110574 107995 111616 98257 93202
Total Long Term Debt 26888 29985 32635 26494 27684
Long Term Debt 26888 29985 32635 26494 27684
Deferred Income Tax 6374 7487 7214 5958 7506
Other Liabilities, Total 21510 25297 29274 29841 26782
Total Equity 76804 74023 63278 59471 59752
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 3120 3120 3120 3120 3120
Retained Earnings (Accumulated Deficit) 128345 123060 113890 110659 106216
Treasury Stock - Common -41694 -39099 -38490 -38417 -34362
Unrealized Gain (Loss) -27 -3 1 0 0
Other Equity, Total -12940 -13055 -15243 -15891 -15222
Total Liabilities & Shareholders’ Equity 187378 182018 174894 157728 152954
Total Common Shares Outstanding 2613.6 2628.97 2632.51 2632.51 2662.32
Other Current Assets, Total 0 94 950
Long Term Investments 576 1884 1481 1148 511
Apr 2023 Apr 2023 Jan 2023 Oct 2022 Jul 2022
Total Current Assets 64388 55294 65236 63847
Cash and Short Term Investments 24613 23519 34079 32568
Cash 4674 4926 4037 3337
Cash & Equivalents 3364 5368 1516 1968
Short Term Investments 16575 13225 28526 27263
Total Receivables, Net 16350 16160 15890 16139
Accounts Receivable - Trade, Net 16350 16160 15890 16139
Total Inventory 12809 12483 11675 11437
Prepaid Expenses 2921 3132 3592 3703
Total Assets 195969 187378 175124 177724
Property/Plant/Equipment, Total - Net 20174 20903 18152 18354
Property/Plant/Equipment, Total - Gross 50367 49253 46681 47144
Accumulated Depreciation, Total -30193 -29450 -28529 -28790
Goodwill, Net 45575 45231 33383 34166
Intangibles, Net 47448 48325 40336 42408
Long Term Investments 505 576 1884 1340
Other Long Term Assets, Total 17879 17049 16133 17609
Total Current Liabilities 60373 55802 45543 44821
Accounts Payable 9909 11703 10153 9765
Accrued Expenses 28219 29201 28980 28771
Notes Payable/Short Term Debt 16900 11220 3900 3800
Current Port. of LT Debt/Capital Leases 1079 1551 524 505
Other Current Liabilities, Total 4266 2127 1986 1980
Total Liabilities 125100 110574 100525 101367
Total Long Term Debt 34928 26888 27603 28292
Long Term Debt 34928 26888 27603 28292
Deferred Income Tax 4417 6374 4946 5015
Other Liabilities, Total 25382 21510 22433 23239
Total Equity 70869 76804 74599 76357
Common Stock 3120 3120 3120 3120
Retained Earnings (Accumulated Deficit) 124558 128345 127917 126216
Treasury Stock - Common -44183 -41694 -41146 -39136
Unrealized Gain (Loss) -10 -27 -38 -36
Other Equity, Total -12616 -12940 -15254 -13807
Total Liabilities & Shareholders’ Equity 195969 187378 175124 177724
Total Common Shares Outstanding 2598.32 2613.6 2616.88 2629.03
Preferred Stock - Non Redeemable, Net 0
Other Current Assets, Total 7695
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 17941 20878 14714 15119 15297
Cash From Operating Activities 21194 23410 23536 23416 22201
Cash From Operating Activities 6970 7390 7231 7009 6929
Deferred Taxes -1663 -2079 -1141 -2476 -1016
Non-Cash Items 1957 1459 42 -101 988
Cash Taxes Paid 5223 4768 4619 4191 4570
Cash Interest Paid 1915 990 904 995 1049
Changes in Working Capital -4011 -4238 2690 3865 3
Cash From Investing Activities -12371 -8683 -20825 -6194 -3167
Capital Expenditures -4009 -3652 -3347 -3498 -3670
Other Investing Cash Flow Items, Total -8362 -5031 -17478 -2696 503
Cash From Financing Activities -8871 -14047 -6120 -18015 -18510
Financing Cash Flow Items 65 395 -627 575 -148
Total Cash Dividends Paid -11682 -11032 -10481 -9917 -9494
Issuance (Retirement) of Stock, Net -4706 -2420 -2107 -5792 -4919
Issuance (Retirement) of Debt, Net 7452 -990 7095 -2881 -3949
Foreign Exchange Effects -312 -178 89 -9 -241
Net Change in Cash -360 502 -3320 -802 283
Apr 2023 Apr 2023 Jan 2023 Oct 2022 Jul 2022
Net income/Starting Line -68 17941 14421 9963
Cash From Operating Activities 3257 21194 15844 9560
Cash From Operating Activities 1880 6970 5198 3513
Deferred Taxes -1543 -1663 -2488 -2349
Non-Cash Items 725 1957 1485 1175
Changes in Working Capital 2263 -4011 -2772 -2742
Cash From Investing Activities 3315 -12371 -7974 -6273
Capital Expenditures -863 -4009 -2422 -1470
Other Investing Cash Flow Items, Total 4178 -8362 -5552 -4803
Cash From Financing Activities 6138 -8871 -10571 -6646
Financing Cash Flow Items -252 65 1806 802
Total Cash Dividends Paid -2942 -11682 -8728 -5758
Issuance (Retirement) of Stock, Net -3548 -4706 -3808 -1730
Issuance (Retirement) of Debt, Net 12880 7452 159 40
Foreign Exchange Effects 28 -312 -431 -145
Net Change in Cash 12738 -360 -3132 -3504
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 10.2333 246418524 569768 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 5.8901 141833756 1568633 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.3448 128702928 -1152148 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.0638 49697798 990298 2023-06-30 LOW
State Farm Insurance Companies Insurance Company 1.3154 31675492 0 2023-06-30 LOW
Capital International Investors Investment Advisor 1.1555 27825795 10724110 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0836 26093398 2295051 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 1.0091 24299765 1144263 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 0.9533 22955840 -2430935 2023-06-30 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.9284 22355142 92730 2023-06-30 LOW
MFS Investment Management Investment Advisor/Hedge Fund 0.8348 20102965 -288668 2023-06-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.827 19914659 -1746201 2023-06-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.8215 19782007 1046097 2023-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.7854 18913505 2153767 2023-06-30 LOW
JP Morgan Asset Management Investment Advisor 0.7349 17697419 2080595 2023-06-30 LOW
Wells Fargo Advisors Research Firm 0.714 17193465 15312 2023-06-30 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.7111 17123285 -23034 2023-06-30 LOW
BofA Global Research (US) Research Firm 0.7067 17017658 -3806531 2023-06-30 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 0.6822 16427920 117449 2023-06-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.6702 16139108 -242372 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Johnson & Johnson Company profile

What is Johnson & Johnson?

Johnson & Johnson is a holding company with its subsidiaries involved in the production and distribution of consumer healthcare products, medical devices and pharmaceutical products. Its consumer segment is represented by the brands Johnson's, Clean & Clear, Le Petite Marseillais and others. The pharmaceutical division ships products for almost all therapeutic fields and treatments for autoimmune disorders. The medical division manufactures devices for orthopaedic, diabetes care and other fields.

Financial stability has been one of Johnson & Johnson’s hallmarks for decades. The company has raised its dividend for 55 successive years, and remains one of just two U.S. companies to have a triple-A credit rating.Fortune included Johnson & Johnson in its list of the largest American corporations.

Johnson & Johnson also prides itself on its corporate social responsibility, and sets out its values in a Credo. In it, the company declares: “We believe our first responsibility is to the doctors, nurses and patients, to mothers and fathers and all others who use our products and services […] We must constantly strive to reduce our costs in order to maintain reasonable prices […] Our suppliers and distributors must have an opportunity to make a fair profit.”

Who are the key people at Johnson & Johnson?

Alex Gorsky is Chairman of the Board of Directors and Chief Executive Officer. Other key figures include Chief Financial Officer Dominic Caruso; Joaquin Duato, Worldwide Chairman, Pharmaceuticals; Jorge Mesquita, Worldwide Chairman, Consumer; and Ashley McEvoy, Company Group Chairman, Consumer Medical Devices.

What is the modern history of Johnson & Johnson?

Johnson & Johnson was founded by three brothers in 1885, incorporated in 1887, and chaired by successive members of the Johnson family until 1963. The company was listed in 1944 and steadily expanded from its home market to Latin America, Europe, Africa and Asia. In 1959, Johnson & Johnson acquired pharmaceutical manufacturer Cilag AG – a big landmark for its pharmaceutical division. The medical and consumer health divisions saw major growth in the latter decades of the 20thcentury.

What are the latest developments at Johnson & Johnson?

In its full year 2017 results, Johnson & Johnson reported worldwide sales of $76.5 billion, an increase of 6.3% on the previous year.Excluding the impact of acquisitions and divestitures, worldwide sales for 2017 were 2.4% higher than in 2016.Net earnings for the full year 2017 were $1.3 billion, and adjusted full year earnings per share were $7.30, an increase of 8.5% on 2016.

The Johnson & Johnson share price, which hovered between $50 and $60 for most of the first decade of this century, started taking off in 2012. By May 2014 the shares were trading at over $100, and in January 2018 they went as high as $147. As of 3 April 2018, they stood at just over $127. To find out how the shares are doing right now, follow Capital.com. Our JNJ chart puts all the information at your fingertips.

Where does Johnson & Johnson operate?

Johnson & Johnson is headquartered in New Brunswick in the U.S. state of New Jersey. The company’s 250 or so subsidiaries operate in 60 countries around the world, and its products are sold in more than 175 countries. So it’s a truly global company, with high levels of brand recognition.

Where is Johnson & Johnson traded?

Johnson & Johnson is listed on the New York Stock Exchange (NYSE), and the shares are a component of the Dow Jones Industrial Average. Check out Capital.com for the latest JNJ chart. We’ll keep you up to date and in the picture.

Industry: Pharmaceuticals (NEC)

One Johnson & Johnson Plaza
NEW BRUNSWICK
NEW JERSEY 08933
US

Income Statement

  • Annual
  • Quarterly

News

How to Trade The Triple Top

Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

14:13, 27 September 2023
USA flag on the background of stock charts. Financial system in USA

Q4 lookahead: US indices starting to show signs of trouble?

US indices start to draw attention as traders focus on the outlook for Q4.

07:20, 27 September 2023

USD/JPY Climbs Towards Key Highs

USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

11:32, 26 September 2023

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

People also watch

ETH/USD

1,603.27 Price
+0.870% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

US100

14,628.50 Price
+0.450% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 1.8

Oil - Crude

94.10 Price
+4.330% 1D Chg, %
Long position overnight fee 0.0587%
Short position overnight fee -0.0806%
Overnight fee time 21:00 (UTC)
Spread 0.030

XRP/USD

0.51 Price
-0.410% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading